Phenotypic changes in vesicular compartments are an early pathological hallmark of many peripheral and central diseases. For example, accurate assessment of early endosome pathology is crucial to the study of Down syndrome (DS) and Alzheimer's disease (AD), as well as other neurological disorders with endosomal-lysosomal pathology. We describe a method for quantification of immunolabeled early endosomes within transmitter-identified basal forebrain cholinergic neurons (BFCNs) using 3-dimensional (3D) reconstructed confocal z-stacks employing Imaris software. Quantification of 3D reconstructed z-stacks was performed using two different image analysis programs ImageJ and Imaris. We found ImageJ consistently overcounted the number of early endosomes present within individual BFCNs. Difficulty separating densely packed early endosomes within defined BFCNs was observed in ImageJ compared to Imaris. Previous methods quantifying endosomal-lysosomal pathology relied on confocal microscopy images taken in a si 3D space readily achievable. Brain-computer interfaces (BCI) permits humans to interact with machines by decoding brainwaves to command for a variety of purposes. Convolutional neural networks (ConvNet) have improved the state-of-the-art of motor imagery decoding in an end-to-end approach. However, shallow ConvNets usually perform better than their deep counterparts. Thus, we aim to design a novel ConvNet that is deeper than the existing models, with an increase in terms of performances, and with optimal complexity. We develop a ConvNet based on Inception and Xception architectures that uses convolutional layers to extract temporal and spatial features. We adopt separable convolutions and depthwise convolutions to enable faster and efficient ConvNet. Then, we introduce a new block that is inspired by Inception to learn more rich features to improve the classification performances. The obtained results are comparable with other state-of-the-art techniques. Also, the weights of the convolutional layers give us some insights onto the learned features and reveal the most relevant ones. We show that our model significantly outperforms Filter Bank Common Spatial Pattern (FBCSP), Riemannian Geometry (RG) approaches, and ShallowConvNet (p < 0.05). The obtained results prove that motor imagery decoding is possible without handcrafted features. The obtained results prove that motor imagery decoding is possible without handcrafted features. Differential DNA methylation associated with allergy might provide novel insights into the shared or unique etiology of asthma, rhinitis, and eczema. We sought to identify DNA methylationprofilesassociated with childhood allergy. Within the European Mechanisms of the Development of Allergy (MeDALL) consortium, we performed an epigenome-wide association study of whole blood DNA methylation by using a cross-sectional design. Allergy was defined as having symptoms from at least 1 allergic disease (asthma, rhinitis, or eczema) and positive serum-specific IgE to common aeroallergens. The discovery study included 219 case patients and 417 controls at age 4 years and 228 case patients and 593 controls at age 8 years from 3 birth cohorts, with replication analyses in 325 case patients and 1111 controls. We performed additional analyses on 21 replicated sites in 785 case patients and 2124 controls by allergic symptoms only from 8 cohorts, 3 of which were not previously included in analyses. We identified 80 differentially methylated CpG sites that showed a 1% to 3% methylation difference in the discovery phase, of which 21 (including 5 novel CpG sites) passed genome-wide significance after meta-analysis. All 21 CpG sites were also significantly differentially methylated with allergic symptoms and shared between asthma, rhinitis, and eczema. The 21 CpG sites mapped to relevant genes, including ACOT7, LMAN3, and CLDN23. All 21 CpG sties were differently methylated in asthma in isolated eosinophils, and 10 were replicated in respiratory epithelium. Reduced whole blood DNA methylation at 21 CpG sites was significantly associated with childhood allergy. The findings provide novel insights into the shared molecular mechanisms underlying asthma, rhinitis, and eczema. Reduced whole blood DNA methylation at 21 CpG sites was significantly associated with childhood allergy. The findings provide novel insights into the shared molecular mechanisms underlying asthma, rhinitis, and eczema. Extensive data available in electronic health records (EHRs) have the potential to improve asthma care and understanding of factors influencing asthma outcomes. However, this work can be accomplished only when the EHR data allow for accurate measures of severity, which at present are complex and inconsistent. Our aims were to create and evaluate a standardized pediatric asthma severity phenotype based in clinical asthma guidelines for use in EHR-based health initiatives and studies and also to examine the presence and absence of these data in relation to patient characteristics. We developed an asthma severity computable phenotype and compared the concordance of different severity components contributing to the phenotype to trends in the literature. We used multivariable logistic regression to assess the presence of EHR data relevant to asthma severity. The asthma severity computable phenotype performs as expected in comparison with national statistics and the literature. Severity classification for a child is maximized when based on the long-term medication regimen component and minimized when based only on the symptom data component. Use of the severity phenotype results in better, clinically grounded classification. https://www.selleckchem.com/products/mycmi-6.html Children for whom severity could be ascertained from these EHR data were more likely to be seen for asthma in the outpatient setting and less likely to be older or Hispanic. Black children were less likely to have lung function testing data present. We developed a pragmatic computable phenotype for pediatric asthma severity that is transportable to other EHRs. We developed a pragmatic computable phenotype for pediatric asthma severity that is transportable to other EHRs.